Tricares
French tech company | Builders Republic
About
Medtech company developing the Topaz transcatheter system to replace a failing tricuspid heart valve without open surgery — a self-expanding nitinol dual-stent prosthesis carrying a biological trileaflet valve, delivered through a vein from the groin to treat tricuspid regurgitation.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series C
- Founded
- 2013
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 46 M€ raised since 2020
Funding rounds
- Series C — 2024
Investors
- 415 Capital
- Andera Partners
- Bayern Kapital
- Biomed Partners
- Crédit Mutuel Innovation
- GO Capital
- Karista
- Wellington Partners